Neuhoff, S.; Schmitt, L.-I.; Liebig, K.C.; Hezel, S.; Tilahun, N.I.; Kleinschnitz, C.; Leo, M.; Hagenacker, T.
Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study. Biomedicines 2025, 13, 1821.
https://doi.org/10.3390/biomedicines13081821
AMA Style
Neuhoff S, Schmitt L-I, Liebig KC, Hezel S, Tilahun NI, Kleinschnitz C, Leo M, Hagenacker T.
Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study. Biomedicines. 2025; 13(8):1821.
https://doi.org/10.3390/biomedicines13081821
Chicago/Turabian Style
Neuhoff, Svenja, Linda-Isabell Schmitt, Kai Christine Liebig, Stefanie Hezel, Nick Isana Tilahun, Christoph Kleinschnitz, Markus Leo, and Tim Hagenacker.
2025. "Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study" Biomedicines 13, no. 8: 1821.
https://doi.org/10.3390/biomedicines13081821
APA Style
Neuhoff, S., Schmitt, L.-I., Liebig, K. C., Hezel, S., Tilahun, N. I., Kleinschnitz, C., Leo, M., & Hagenacker, T.
(2025). Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study. Biomedicines, 13(8), 1821.
https://doi.org/10.3390/biomedicines13081821
